Shengnuo Biology: Controlling shareholder Sino Investment plans to increase its holdings by 40 to 50 million yuan.

SanNuo Biotech announced that its controlling shareholder, Sino Investment, plans to increase its holdings of the company's A shares through the Shanghai Stock Exchange system within 12 months from the disclosure of this announcement. The planned increase in shareholding is between 40 million and 50 million yuan, with funding sources coming from self-owned funds and self-raised funds, with a maximum loan amount not exceeding 45 million yuan and a term of 3 years.